Innovation.net provides insights and discussion on entrepreneurial approaches to growth and innovation. Topics include new business creation, lean startup methods and open innovation among others. It's written by Mike Docherty and the experts at Venture2, a consulting and new ventures firm.
www.venture2.com Venture2 applies entrepreneurial approaches to accelerate new businesses and new sources of growth. We work with established brand companies as well as emerging technology firms to rapidly connect and commercialize breakthrough new products, services and business models. Our business model leverages a small core team and a big network that brings diverse, multi-disciplinary skills from a variety of business management and entrepreneurial backgrounds.
As part of Fab10 (www.fab10.org), the 10th annual Fab Lab Community Meeting, IAAC - the Institute for Advanced Architecture of Catalonia - is holding the Fab Festival on the 5th and 6th of July 2014 (https://www.fab10.org/en/fab-festival). The Fab Festival includes Workshops, Demos, Panels and short talks, gathering members of the International Fab Lab Community, together with the innovative local community and the general public. Members of local groups will hold creative workshops, conferences and events for all ages, a great opportunity for all to partake in the creativity of the city.
Don't miss out on this opportunity to be inspired by and network with some of the world's most innovative people of our time.
As some of you may know, I had the good fortune to work with Dr. Peter Salk MD in the launch of BeyondPolio. Our efforts were focused on driving collaborative innovation efforts toward better and lower cost delivery of IPV (injected Salk vaccines). IPV plays the central role in the developed world in maintaining eradication efforts, while the Sabin vaccine (OPV) is used in the remaining trouble spots in the world (Pakistan, Afghanistan, Nigeria, Somalia and others), primarily because of its ease of administering. If you didn't know (and it makes some interesting reading), Salk and Sabin were rivals in their day and certainly not collaborating with each other.
Because of my involvement with the fight against polio, and my focus on collaboration and innovation, I was recently impressed when Peter Salk (son of polio vaccine pioneer Jonas Salk) came together with Deborah Sabin, BSN, FNP (daughter of Albert Sabin, developer of the oral polio vaccine) in this year’s Rose Parade on the Rotary Foundation's float.
The pair came together both to honor their fathers’ legacies and to announce their continued efforts to rid the world of polio with the continued support of Rotary.
While the Salk and Sabin vaccines were often seen as competing methods of treating the disease, we can see now that the successes of the last 50 years would not have been possible without both vaccines. Collaboration, not competition, is the ultimate result of the two scientists’ work.
Continuing the fight to eradicate polio is the top priority to both Peter Salk and Deborah Sabin, and they recognize the need for continued collaboration to reduce costs, increase availability, and overcome the obstacles that arise along the way.
We’ve learned that combined efforts and a collaborative spirit have been integral in the fight against polio up to this point, despite two “competing” vaccines, and all signs indicate that this lesson will remain true as work continues to end polio once and for all.
Profitability for university tech transfer offices (TTOs) has historically only been available to the smallest percentage of top tier institutions, with 87% of universities failing to break even over a 20 year average. The vast majority of the revenue generated is through licensing opportunities, of which 70% of all income went to the top 10% of universities.
There is clearly a problem with this model, with most TTOs operating in the red year after year.
Instead of focusing on licensing opportunities (usually to the highest bidder), as the profitable, top ranking universities do, the report suggests a shift toward the less common focus of spin-outs and startups. By shifting in this direction, TTOs can foster increased joint responsibility, and break away from a model that restricts technological access to only those universities and license purchasers with the strongest financial backing.
In addition to the report’s recommendations for an increased push for spin-outs and startups, I believe it’s important to foster relationships between corporate and university departments beyond transactional licensing opportunities, as well as increased corporate and venture capital connectivity, to create an environment where research and technology can fuel innovation and commercial scale-up.
University research teams should also take corporate and public perspectives into account when developing research projects, guiding the research toward practical applications of technology to fulfill unmet needs.
When the figures are presented in such a clear cut way, it’s easy to see that a longstanding model of major university and TTO licensing is not an effective method of getting technology and research into the hands of those who can leverage it for the public good. As recent history has shown, true innovation tends to arise from small groups, startups, and special interest spin-outs. The TTO model needs to reflect this reality.
The World Science Festival published an article and slide show from Dr. Peter Salk, son of Dr. Jonas Salk in honor of his father's 99th birthday.
We forgot or take for granted the eradication of polio in the US, from 40,000 cases annually down by 97% after the introduction of the Salk polio vaccine in 1955.
But the disease persists in the developing world, in spite of great efforts from the Global Polio Eradication Initiative (GPEI), Rotary International, the Gates Foundation and others.
Peter's article provides a powerful update to the story and the continuing battle, especially for the need to transition from OPV (oral) based on the Sabine vaccine to the safer and longer term solution of IPV (injected Salk vaccine).
I'm proud to have worked with Peter on the launch of BeyondPolio.org, focused on applying collaborative innovation to the problems of finding new and better ways to deliver IPV and accelerate the eradication of polio and maintaining a polio-free world.
Best of luck and hats of to Dr. Peter Salk for carrying on this work to support his father's legacy.